Cited by 113Antifungal resistance and susceptibilityAntibiotic Resistance in BacteriaFungal Plant Pathogen Control

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance System

Open access

Grossman, Nina T., Pham, Cau D., Cleveland, Angela A., Lockhart, Shawn R.·2015·Antimicrobial Agents and Chemotherapy

Open this paper in CoChat — free account

Abstract

Candida parapsilosis is the second or third most common cause of candidemia in many countries. The Infectious Diseases Society of America recommends fluconazole as the primary therapy for C. parapsilosis candidemia. Although the rate of fluconazole resistance among C. parapsilosis isolates is low in most U.S. institutions, the resistance rate can be as high as 7.5%. This study was designed to assess the mechanisms of fluconazole resistance in 706 incident bloodstream isolates from U.S. hospitals. We sequenced the ERG11 and MRR1 genes of 122 C. parapsilosis isolates with resistant (30 isolates; 4.2%), susceptible dose-dependent (37 isolates; 5.2%), and susceptible (55 isolates) fluconazole MIC values and used real-time PCR of RNA from 17 isolates to investigate the regulation of MDR1. By comparing these isolates to fully fluconazole-susceptible isolates, we detected at least two mechanisms of fluconazole resistance: an amino acid substitution in the 14-α-demethylase gene ERG11 and overexpression of the efflux pump MDR1, possibly due to point mutations in the MRR1 transcription factor that regulates MDR1. The ERG11 single nucleotide polymorphism (SNP) was found in 57% of the fluconazole-resistant isolates and in no susceptible isolates. The MRR1 SNPs were more difficult to characterize, as not all resulted in overexpression of MDR1 and not all MDR1 overexpression was associated with an SNP in MRR1. Further work to characterize the MRR1 SNPs and search for overexpression of other efflux pumps is needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/aac.04613-14

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical and Laboratory Standards Institute
Gressner, A. M., & Arndt, T. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,092
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data
Hellemans, J., Mortier, G., De Paepe, A., Speleman, F., & Vandesompele, J. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r19 · Cited by 4,023
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Accuracy of estimated phylogenetic trees from molecular data
Nei, M., Tajima, F., & Tateno, Y. (1983) · Journal of Molecular Evolution · doi:10.1007/bf02300753 · Cited by 2,532
microsatellite analyser (MSA): a platform independent analysis tool for large microsatellite data sets
Dieringer, D., & Schlötterer, C. (2003) · Molecular Ecology Notes · doi:10.1046/j.1471-8286.2003.00351.x · Cited by 1,594
Candida parapsilosis , an Emerging Fungal Pathogen
Trofa, D. P., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 886
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470
Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008
Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396

Show all 30 references

Sorted by citations

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900
Fluconazole resistance in Candida species: a current perspective
Berkow, E., & Lockhart, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s118892 · Cited by 542
Self-citation
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418
Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents
Santos, G. C. D. O., Vasconcelos, C. C., Lopes, A. J. O., Cartágenes, M. D. S. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 381
Candida parapsilosis: from genes to the bedside
Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-18 · Cited by 327
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A. A., Gabaldón, T., Garcia‐Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., İlkit, M., Lass‐Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 302
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)
Arendrup, M. C., Friberg, N., Ma, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Arendrup, M., Meletiadis, J., Guinea, J., Friberg, N., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.007 · Cited by 248
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Gonçalves, S. S., Souza, A. C. R., Chowdhary, A., Meis, J. F. G. M., & Colombo, A. L. (2016) · Mycoses · doi:10.1111/myc.12469 · Cited by 186
Limited ERG11 Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole Susceptibility
Healey, K. R., Kordalewska, M., Jiménez Ortigosa, C., Singh, A., Berrío, I., Chowdhary, A., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01427-18 · Cited by 165
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145
Emergence of azole-resistantCandida parapsilosiscausing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa
Govender, N. P., Patel, J., Magobo, R. E., Naicker, S. D., Wadula, J., Whitelaw, A. C., Coovadia, Y. M., Kularatne, R. S., Govind, C., Lockhart, S. R., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw091 · Cited by 150
An Azole-Resistant Candida parapsilosis Outbreak: Clonal Persistence in the Intensive Care Unit of a Brazilian Teaching Hospital
Thomaz, D. Y., de Almeida, J. N., Lima, G. M. E., Nunes, M. D. O., Camargo, C. H., Grenfell, R. C., Benard, G., & Negro, G. M. B. D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02997 · Cited by 126
Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae
Souza, A. C. R., Fuchs, B. B., Pinhati, H. M. S., Siqueira, R. A., Hagen, F., Meis, J. F., Mylonakis, E., & Colombo, A. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01177-15 · Cited by 121
First Report of Candidemia Clonal Outbreak Caused by Emerging Fluconazole-Resistant Candida parapsilosis Isolates Harboring Y132F and/or Y132F+K143R in Turkey
Arastehfar, A. A., Daneshnia, F., Polat, S. H., Fang, W., Yaşar, M., Polat, F., Metin, D. Y., Rigole, P., Coenye, T., İlkit, M., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01001-20 · Cited by 112
Resistance to Antifungal Drugs
Ben‐Ami, R., & Kontoyiannis, D. P. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.003 · Cited by 108
Multidrug transporters and alterations in sterol biosynthesis contribute to azole antifungal resistance in Candida parapsilosis
Berkow, E. L., Manigaba, K., Parker, J. E., Barker, K. S., Kelly, S. L., & Rogers, P. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01358-15 · Cited by 95
Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea
Choi, Y. J., Kim, Y., Yong, D., Byun, J., Kim, T. S., Chang, Y. S., Choi, M. J., Byeon, S. A., Won, E. J., Kim, S. H., et al. (2018) · Emerging infectious diseases · doi:10.3201/eid2409.180625 · Cited by 89
Hospital Outbreak of Fluconazole-Resistant Candida parapsilosis: Arguments for Clonal Transmission and Long-Term Persistence
Fekkar, A., Blaize, M., Bouglé, A., Normand, A., Raoelina, A., Kornblum, D., Kamus, L., Piarroux, R., & Imbert, S. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02036-20 · Cited by 85
Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge
Arastehfar, A. A., Polat, S. H., Daneshnia, F., Pan, W., Hafez, A. I., Fang, W., Liao, W., Şahbudak-Bal, Z., Metin, D. Y., de Almeida, J. N., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.676177 · Cited by 86
Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India
Singh, A. K., Singh, P. K., de Groot, T., Kumar, A., Mathur, P., Tarai, B., Sachdeva, N., Upadhyaya, G., Sarma, S., Meis, J. F. G. M., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz029 · Cited by 82
Prevalence and Clonal Distribution of Azole-Resistant Candida parapsilosis Isolates Causing Bloodstream Infections in a Large Italian Hospital
Martini, C., Torelli, R., de Groot, T., Carolis, E. D., Morandotti, G. A., Angelis, G. D., Posteraro, B., Meis, J. F. G. M., & Sanguinetti, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00232 · Cited by 85
Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens
Neji, S., Hadrich, I., Trabelsi, H., Abbes, S., Cheikhrouhou, F., Sellami, H., Makni, F., & Ayadi, A. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0376-2 · Cited by 74
Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates
Arastehfar, A. A., Daneshnia, F., Najafzadeh, M. J., Hagen, F., Mahmoudi, S., Salehi, M., Zarrinfar, H., Namvar, Z., Zareshahrabadi, Z., Khodavaisy, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00206 · Cited by 70
Fluconazole‐resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa
Magobo, R. E., Lockhart, S. R., & Govender, N. P. (2020) · Mycoses · doi:10.1111/myc.13070 · Cited by 69
Assessing the Risk for Resistance and Elucidating the Genetics of Colletotrichum truncatum That Is Only Sensitive to Some DMI Fungicides
Zhang, C., Diao, Y., Wang, W., Hao, J. J., Imran, M., Duan, H., & Liu, X. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01779 · Cited by 68
Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistance
Branco, J., Ola, M., Silva, R. M., Fonseca, E. S. S., Gomes, N. C., Martins-Cruz, C., Silva, A. P., Silva-Dias, A., Pina‐Vaz, C., Erraught, C., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.02.002 · Cited by 67
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain
Alcoceba, E., Gómez, A., Lara-Esbrí, P., Oliver, A., Beltran, A. F., Ayestarán, I., Muñóz, P., Escribano, P., & Guinea, J. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.02.025 · Cited by 66
Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait
Khan, Z., Ahmad, S., Al‐Sweih, N., Mokaddas, E. M., Al-Banwan, K., Alfouzan, W. A., Al‐Obaid, I., Alobaid, K., Asadzadeh, M., Jeragh, A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216250 · Cited by 67
Global Prevalence of Antifungal-Resistant Candida parapsilosis: A Systematic Review and Meta-Analysis
Yamin, D., Hammed-Akanmu, M., Mutair, A. S. A., Alhumaid, S., Rabaan, A. A., & Hajissa, K. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7080188 · Cited by 74
Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy
Zhang, L., Xiao, M., Watts, M. R., Wang, H., Fan, X., Kong, F., & Xu, Y.-C. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1086-6 · Cited by 62
Fluconazole-resistant Candida parapsilosis: A new emerging threat in the fungi arena
Escribano, P., & Guinea, J. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.1010782 · Cited by 65
General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation
Corzo-León, D., Peacock, M., Rodríguez‐Zulueta, P., Salazar-Tamayo, G., & MacCallum, D. M. (2020) · Medical Mycology · doi:10.1093/mmy/myaa098 · Cited by 58
Multidrug transporters of Candida species in clinical azole resistance
Prasad, R., Nair, R., & Banerjee, A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103252 · Cited by 60
Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the C OVID-19 Pandemic
Trevijano-Contador, N., Torres-Cano, A., Carballo-González, C., Puig-Asensio, M., Martín-Gómez, M. T., Jiménez-Martínez, E., Romero, D., Nuvials, F. X., Olmos-Arenas, R., Moretó-Castellsagué, M. C., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac605 · Cited by 54
Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis
Rybak, J. M., Dickens, C. M., Parker, J. E., Caudle, K. E., Manigaba, K., Whaley, S. G., Nishimoto, A. T., Luna-Tapia, A., Roy, S., Zhang, Q., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00651-17 · Cited by 53
An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and Underlying Resistance Mechanisms in Clinical Strains
Salazar, S. B., Simões, R., Pedro, N. A., Pinheiro, M. J. F., Carvalho, M. F. N. N., & Mira, N. P. (2020) · Journal of Fungi · doi:10.3390/jof6010023 · Cited by 58
Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait
Asadzadeh, M., Ahmad, S., Al‐Sweih, N., & Khan, Z. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0336 · Cited by 52
Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution
Díaz-García, J., Gómez, A., Alcalá, L., Reigadas, E., Sánchez‐Carrillo, C., Pérez‐Ayala, A., de la Pedrosa, E. G., González‐Romo, F., Amador, P. M., Cuétara, M. S., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00710-22 · Cited by 52
Fluconazole and Voriconazole Resistance in Candida parapsilosis Is Conferred by Gain-of-Function Mutations in MRR1 Transcription Factor Gene
Branco, J., Silva, A. P., Silva, R. M., Silva-Dias, A., Pina‐Vaz, C., Butler, G., Rodrigues, A. G., & Miranda, I. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00842-15 · Cited by 49
Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011–16 study
Fuller, J., Dingle, T. C., Bull, A., Shokoples, S., Laverdière, M., Baxter, M. R., Adam, H. J., Karlowsky, J. A., Zhanel, G. G., Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD, et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz287 · Cited by 47
Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU
Daneshnia, F., de Almeida, J. N., Arastehfar, A. A., Lombardi, L., Shor, E., Moreno, L., Mendes, A. V. A., Barberino, M. G., Thomaz, D. Y., Butler, G., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2117093 · Cited by 47
Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts, Candida orthopsilosis, and Candida metapsilosis: An Iranian Multicenter Study (2014–2019)
Arastehfar, A. A., Khodavaisy, S., Daneshnia, F., Najafzadeh, M. J., Mahmoudi, S., Charsizadeh, A., Salehi, M., Zarrinfar, H., Raeisabadi, A., Dolatabadi, S., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00264 · Cited by 49
Strong Synergism of Palmatine and Fluconazole/Itraconazole Against Planktonic and Biofilm Cells of Candida Species and Efflux-Associated Antifungal Mechanism
Wang, T., Shao, J., Da, W., Li, Q., Shi, G., Wu, D., & Wang, C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02892 · Cited by 43
Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species
Silva, D. B. D. S., Rodrigues, L. M. C., Almeida, A. A. D., Oliveira, K. M. P. D., & Grisolia/, A. B. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150400 · Cited by 42
Emergence and circulation of azole-resistant C. albicans, C. auris and C. parapsilosis bloodstream isolates carrying Y132F, K143R or T220L Erg11p substitutions in Colombia
Ceballos-Garzón, A., Peñuela, A., Valderrama, S., Vargas‐Casanova, Y., Ariza, B., & Parra‐Giraldo, C. M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1136217 · Cited by 43
Cross‐resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?
Rocha, M. F. G., de Alencar, L. P., Paiva, M. A. N., Melo, L. M., Bandeira, S. P., de Ponte, Y. B., Sales, J. A., Guedes, G. M. D. M., Castelo‐Branco, D. D. S. C. M., Bandeira, T. J. P. G., et al. (2016) · Mycoses · doi:10.1111/myc.12457 · Cited by 38
Exposure of Candida parapsilosis complex to agricultural azoles: An overview of the role of environmental determinants for the development of resistance
Brilhante, R. S. N., de Alencar, L. P., Bandeira, S. P., Sales, J. A., Evangelista, A. J. D. J., Serpa, R., Cordeiro, R. D. A., Pereira‐Neto, W. D. A., Sidrim, J. J. C., Castelo‐Branco, D. D. S. C. M., et al. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.09.096 · Cited by 38
Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance
Doorley, L. A., Rybak, J. M., Berkow, E. L., Zhang, Q. H., Morschhäuser, J., & Rogers, P. D. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00289-22 · Cited by 34
Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years
Demirci‐Duarte, S., Arıkan-Akdağlı, S., & Gülmez, D. (2021) · Mycoses · doi:10.1111/myc.13296 · Cited by 36
Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development
Ghobadi, E., Saednia, S., & Emami, S. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114161 · Cited by 31
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates
Rizzato, C., Poma, N. V., Zoppo, M., Posteraro, B., Mello, E., Bottai, D., Lupetti, A., Sanguinetti, M., & Tavanti, A. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky122 · Cited by 29
Candida parapsilosis Sensu Stricto Antifungal Resistance Mechanisms and Associated Epidemiology
Franconi, I., Rizzato, C., Poma, N. V., Tavanti, A., & Lupetti, A. (2023) · Journal of Fungi · doi:10.3390/jof9080798 · Cited by 27
Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis
Morio, F., Lombardi, L., Binder, U., Logé, C., Robert, E., Grässle, D., Bodin, M., Lass‐Flörl, C., Butler, G., & Pape, P. L. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz204 · Cited by 29
Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation
Branco, J., Ryan, A. P., Silva, A. P., Butler, G., Miranda, I. M., & Rodrigues, A. G. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.08.014 · Cited by 25
Molecular and Epidemiological Investigation of Fluconazole-resistant Candida parapsilosis —Georgia, United States, 2021
Misas, E., Witt, L. S., Farley, M. M., Thomas, S., Jenkins, E. N., Gade, L., Peterson, J. G., Restrepo, A. M., Fridkin, S. K., Lockhart, S. R., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae264 · Cited by 22
Candida parapsilosis Colony Morphotype Forecasts Biofilm Formation of Clinical Isolates
Gómez-Molero, E., De-la-Pinta, I., Fernández-Pereira, J., Groß, U., Weig, M., Quindós, G., de Groot, P. W. J., & Bader, O. (2021) · Journal of Fungi · doi:10.3390/jof7010033 · Cited by 22
Evolution of Fluconazole Resistance Mechanisms and Clonal Types of Candida parapsilosis Isolates from a Tertiary Care Hospital in South Korea
Kim, T. Y., Huh, H. J., Lee, G. Y., Choi, M. J., Yu, H., Cho, S. Y., Chang, Y. S., Kim, Y., Shin, J. H., & Lee, N. Y. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00889-22 · Cited by 23
Regulation of ERG3, ERG6, and ERG11 Genes in Antifungal-Resistant isolates of Candida parapsilosis
Lotfali, E., Ghajari, A., Kordbacheh, P., Zaini, F., Mirhendi, H., Mohammadi, R., Noorbakhsh, F., & Rezaie, S. (2017) · Iranian Biomedical Journal · doi:10.18869/acadpub.ibj.21.4.275 · Cited by 22
First Canadian report of transmission of fluconazole-resistant Candida parapsilosis within two hospital networks confirmed by genomic analysis
McTaggart, L. R., Eshaghi, A., Hota, S. S., Poutanen, S. M., Johnstone, J., Luca, D. G. D., Bharat, A., Patel, S. N., & Kus, J. V. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.01161-23 · Cited by 19
Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host
Ruma, Y. N., Keniya, M. V., Tyndall, J. D. A., & Monk, B. C. (2022) · Journal of Fungi · doi:10.3390/jof8010069 · Cited by 21
Candida auris and some Candida parapsilosis strains exhibit similar characteristics on CHROMagarTM Candida Plus
Sasoni, N., Maidana, M., Rapela, M. G. L., Morales-López, S. E., Berrío, I., Gamarra, S. P., & García‐Effrón, G. (2022) · Medical Mycology · doi:10.1093/mmy/myac062 · Cited by 20
Analysis of the prochloraz‐Mn resistance risk and its molecular basis in Mycogone rosea from Agaricus bisporus
Du, Y., Shi, N., Ruan, H., Miao, J., Yan, H., Shi, C., Chen, F., & Liu, X. (2021) · Pest Management Science · doi:10.1002/ps.6509 · Cited by 19
Analysis of clinical Candida parapsilosis isolates reveals copy number variation in key fluconazole resistance genes
Bergin, S. A., Doorley, L. A., Rybak, J. M., Wolfe, K. H., Butler, G., Cuomo, C. A., & Rogers, P. D. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01619-23 · Cited by 19
Cationic RuII Cyclopentadienyl Complexes with Antifungal Activity against Several Candida Species
Golbaghi, G., Groleau, M., Santos, Y. L. D. L., Doucet, N., Déziel, É., & Castonguay, A. (2020) · ChemBioChem · doi:10.1002/cbic.202000254 · Cited by 18
Efficacy of LAMB against Emerging Azole- and Multidrug-Resistant Candida parapsilosis Isolates in the Galleria mellonella Model
Binder, U., Arastehfar, A. A., Schnegg, L., Hörtnagl, C., Polat, S. H., Perlin, D. S., & Lass‐Flörl, C. (2020) · Journal of Fungi · doi:10.3390/jof6040377 · Cited by 18
Fluconazole‐resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole‐resistance profiles associated with the Y132F ERG11p substitution
Mesquida, A., Alcoceba, E., Padilla, E., Ramírez, A., Merino, P., González‐Romo, F., Carolis, E. D., Sanguinetti, M., Mantecón‐Vallejo, M. D. L. Á., Muñoz‐Algarra, M., et al. (2024) · Mycoses · doi:10.1111/myc.13706 · Cited by 16
Vaginal mycobiome characteristics and therapeutic strategies in vulvovaginal candidiasis (VVC): differentiating pathogenic species and microecological features for stratified treatment
Liu, Z., Yang, H., Huang, R., Li, X., Sun, T., & Zhu, L. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00284-24 · Cited by 17
Whole-Genome and Targeted-Amplicon Sequencing of Fluconazole-Susceptible and -Resistant Candida parapsilosis Isolates from Kuwait Reveals a Previously Undescribed N1132D Polymorphism in CDR1
Asadzadeh, M., DASHTI, M. H., Ahmad, S., Alfouzan, W. A., & Alameer, A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01633-20 · Cited by 15
Precise genome editing underlines the distinct contributions of mutations in ERG11 , ERG3 , MRR1 , and TAC1 genes to antifungal resistance in Candida parapsilosis
Hartuis, S., Ourliac‐Garnier, I., Robert, E., Albassier, M., Duchesne, L., Beaufils, C., Kuhn, J., Pape, P. L., & Morio, F. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00022-24 · Cited by 13
Genetic Manipulation as a Tool to Unravel Candida parapsilosis Species Complex Virulence and Drug Resistance: State of the Art
Zoppo, M., Poma, N. V., Luca, M. D., Bottai, D., & Tavanti, A. (2021) · Journal of Fungi · doi:10.3390/jof7060459 · Cited by 14
Emerging antifungal resistance in Candida parapsilosis: the end of the innocence
Guinea, J., Escribano, P., Cadeau, M., Lombardi, L., & Morio, F. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00173-5 · Cited by 15
Loop-mediated isothermal amplification for Candida species surveillance in under-resourced setting: a review of evidence
Owoicho, O., Olwal, C. O., Tettevi, E. J., Atu, B. O., & Durugbo, E. U. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2109963 · Cited by 11
Determinants of fluconazole resistance and the efficacy of fluconazole and milbemycin oxim combination against Candida parapsilosis clinical isolates from Brazil and Turkey
Daneshnia, F., Polat, S. H., İlkit, M., Shor, E., de Almeida, J. N., Favarello, L. M., Colombo, A. L., Arastehfar, A. A., & Perlin, D. S. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.906681 · Cited by 11
ERG11 gene polymorphisms and susceptibility to fluconazole in Candida isolates from diabetic and kidney transplant patients
Benedetti, V. P., Savi, D. C., Aluízio, R., Adamóski, D., Kava, V. M., Galli-Terasawa, L. V., & Glienke, C. (2019) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0473-2018 · Cited by 13
Antifungal Activity of Cymbopogon flexuosus Essential Oil and its Effect on Biofilm Formed by Candida parapsilosis and Candida tropicalis on Polystyrene and Polyvinyl Plastic Surfaces
Al-Ghanayem, A. A. (2023) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/001954641705 · Cited by 8
Molecular Cloning, Heterologous Expression, Purification, and Evaluation of Protein–Ligand Interactions of CYP51 of Candida krusei Azole-Resistant Fungal Strain
Tsybruk, T. V., Kaluzhskiy, L. A., Mezentsev, Y. V., Makarieva, T. N., Tabakmakher, K. M., Ivanchina, N. V., Dmitrenok, P. S., Baranovsky, A. V., Gilep, A. A., & Ivanov, A. S. (2023) · Biomedicines · doi:10.3390/biomedicines11112873 · Cited by 8
New pharmacotherapeutic strategies for drug-resistant Candida infections: a review
Raposa, J., & Vázquez, J. A. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2433605 · Cited by 8
Phenotypic and genotypic characterization of Candida parapsilosis complex isolates from a Lebanese hospital
Hady, R. E., Fattouh, N., Finianos, M., Bitar, I., Fakih, T., Husni, R., & Khalaf, R. A. (2025) · Scientific Reports · doi:10.1038/s41598-024-84535-5 · Cited by 10
First isolation of Candida metapsilosis in Kuwait, an emerging global opportunistic pathogen
Asadzadeh, M., Ahmad, S., Al‐Sweih, N., Gulati, R. R., & Khan, Z. U. (2015) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2015.11.001 · Cited by 8
Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl
Biermann, A. R., & Hogan, D. A. (2022) · mSphere · doi:10.1128/msphere.00124-22 · Cited by 8
High efficacy fluconazole loaded ZnO ‐poly (vinyl alcohol) nanocomposite: Interpretive breakpoints for biological applications
Das, A., Ringu, T., Ghosh, S., & Pramanik, N. (2024) · Journal of Vinyl and Additive Technology · doi:10.1002/vnl.22098 · Cited by 7
Bridging the Gap to Non-toxic Fungal Control: Lupinus-Derived Blad-Containing Oligomer as a Novel Candidate to Combat Human Pathogenic Fungi
Pinheiro, A. M., Carreira, A., Prescott, T. A. K., Ferreira, R. B., & Monteiro, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01182 · Cited by 8
Pathogenic yeasts recovered from acne vulgaris: Molecular characterization and antifungal susceptibility pattern
Omran, A. N., & Mansori, A. G. (2018) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_351_17 · Cited by 7
Clinical impact of fluconazole-resistant Candida parapsilosis : a narrative review
Bartalucci, C., Vena, A., Giacobbe, D. R., & Bassetti, M. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2544443 · Cited by 6
In vitro Antifungal Activities of Fluconazole, Camellia sinensis and Cydonia oblonga Leaf Extracts Against Candida Species Isolated from Blood Cultures
Hancı, H., Coşkun, M. V., Uyanik, M. H., Sezen, S., & İgan, H. (2019) · Bezmialem Science · doi:10.14235/bas.galenos.2018.2599 · Cited by 6
Scanning ion-conductance microscopy technique for studying the topography and mechanical properties of Candida parapsilosis yeast microorganisms
Savin, N. A., Erofeev, A. S., Колмогоров, В., Salikhov, S. V., Efremov, Y. M., Timashev, P. S., Grammatikova, N. E., Levshin, I. B., Edwards, C., Korchev, Y. E., et al. (2022) · Biomaterials Science · doi:10.1039/d2bm00964a · Cited by 6
Fluconazole‐resistant Candida parapsilosis complex candidemia and analysis of mutations in the ERG11 gene from Pakistan
Zeeshan, M., Memon, S., Malick, A. A., Naqvi, S. F., Farooqi, J. Q., Ghanchi, N. K., & Jabeen, K. (2023) · Mycoses · doi:10.1111/myc.13677 · Cited by 6
Resistance to Azoles in Candida parapsilosis Isolates from Spain Is Associated with an Impairment in Filamentation and Biofilm Formation
Torres-Cano, A., de Armentia, C., Roldán, A., López‐Peralta, E., Manosalva, J., Amador, P. M., González‐Romo, F., Puig‐Asensio, M., Ardanuy, C., Martín-Gómez, M. T., et al. (2025) · Journal of Fungi · doi:10.3390/jof11040299 · Cited by 4
Shift in Candida species causing candidemia: A seven-year study from a university hospital and evaluation of the rise of Candida parapsilosis sensu stricto
Tanrıverdi, E. S., Yakupoğulları, Y., Duman, Y., Tekerekoğlu, M. S., & Otlu, B. (2025) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2025.04.004 · Cited by 4
Phenotypic and genomic characterization of azole resistance in Portuguese Candida parapsilosis isolates
Papuc, A.-M., Veríssimo, C., Simões, H., Toscano, C., Gomes, J. P., Mixão, V., & Sabino, R. (2025) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2025.1713961 · Cited by 4
Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis
Prusty, J. S., Kumar, A., & Kumar, A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2418125 · Cited by 5
Global emergence of resistance to fluconazole and voriconazole in Candida parapsilosis in tertiary hospitals in Spain during the COVID-19 pandemicPreprint
Zaragoza, Ó., Alcázar‐Fuoli, L., Trevijano‐Contador, N., Torres-Cano, A., Carballo-González, C., Puig‐Asensio, M., Martín-Gómez, M. T., Jiménez‐Martínez, E., Herrero, D. R., Nuvials, X., et al. (2022) · medRxiv · doi:10.1101/2022.06.06.22275514 · Cited by 4
Does Systemic Methotrexate Therapy Induce Azole Resistance among Endogenous Candida Strains?
Żyrek, D., Nowicka, J., Pajączkowska, M., & Morgiel, E. (2021) · Antibiotics · doi:10.3390/antibiotics10111302 · Cited by 3
Improved Laboratory Synthesis of YC-071, a Potent Azole Antifungal Agent
Zheng, Y., Qian, A., Ling, C., Cao, X., Cui, Y., & Yang, Y. (2017) · Journal of Chemical Research · doi:10.3184/174751917x14902201357419 · Cited by 3
High‐Resolution Melting Assay to Detect the Mutations That Cause the Y132F and G458S Substitutions at the ERG11 Gene Involved in Azole Resistance in Candida parapsilosis
Trevijano‐Contador, N., López‐Peralta, E., López‐López, J., Roldán, A., de Armentia, C., & Zaragoza, Ó. (2024) · Mycoses · doi:10.1111/myc.13811 · Cited by 2
3 / CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates
Rizzato, C. (2018) · doi:10.26226/morressier.5ac39997d462b8028d899df8 · Cited by 2
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0134 · Cited by 2
Complexo Candida parapsilosis: identificação molecular das espécies, análise proteômica dos biofilmes por MALDI-TOF MS e investigação de um surto envolvendo isolados clínicos resistentes aos azólicos
Thomaz, D. Y. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-13022019-163819 · Cited by 1
Circulation of Fluconazole-Resistant C. albicans, C. auris and C. parapsilosis Bloodstream Isolates Carrying Y132F, K143R or T220L Erg11p Substitutions in ColombiaPreprint
Ceballos-Garzón, A., Peñuela, A., Valderrama, S., Vargas‐Casanova, Y., Ariza, B., & Parra‐Giraldo, C. M. (2022) · medRxiv · doi:10.1101/2022.11.30.22282939 · Cited by 1

Authors: Grossman, N. T., Pham, C. D., Cleveland, A. A., & Lockhart, S. R.
Affiliations: Centers for Disease Control and Prevention (US)
ORCID: Grossman, Nina T.
Pham, Cau D.
Cleveland, Angela A.
Lockhart, Shawn R.
Venue: Antimicrobial Agents and Chemotherapy
Publisher: American Society for Microbiology
Published: 2015-02
Volume: 59
Issue: 2
Pages: 1030-1037
ISSN: 0066-4804 (ISSN-L)
1098-6596
DOI: 10.1128/aac.04613-14
PMC: PMC4335858
OpenAlex: W2099674708
Cited by: 112
References: 30
Citations by year: 2026: 2 · 2025: 8 · 2024: 8 · 2023: 11 · 2022: 19 · 2021: 8 · 2020: 13 · 2019: 12 · 2018: 10 · 2017: 11 · 2016: 4 · 2015: 6
FWCI: 4.90
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Antimicrobial Agents and Chemotherapy (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords: Candida parapsilosis, fluconazole resistance, candidemia, ERG11, MRR1, single nucleotide polymorphisms, bloodstream isolates, resistance monitoring
MeSH terms: Antifungal Agents, Candida, Microbial Sensitivity Tests, Fluconazole, Gene Expression Regulation, Fungal, Drug Resistance, Fungal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance System

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks